announced today that it has completed patient enrollment in its Phase 2 clinical trial for Purified Exosome Product™ (PEP™) in the treatment of Diabetic Foot Ulcers (DFUs). This milestone ...

However, the effect of mesenchymal stem cells or their exosomes on macrophage efferocytosis of dying heart-muscle cells—in animal models with or without diabetes—has not been studied, Krishnamurthy ...